Compare Panca Global Kapital Tbk. (PEGE) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Panca Global Kapital Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Panca Global Kapital Tbk. trades at Rp130 (market cap 487.35B, 11.11M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Panca Global Kapital Tbk. is far larger — about 4.7× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PEGE | SCPI | |
|---|---|---|
Market Cap | 487.35B | 104.4B |
Volume | 11.11M | — |
Lot | 111.15K | — |
Turnover | 1.42B | — |
Average Price | 127.8 | — |
Value | 1.42B | — |
Indicative Equilibrium Price | 130 | — |
Indicative Equilibrium Volume | 1.46K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Panca Global Kapital Tbk.
PT Panca Global Securities Tbk. (the Company) was established based on notarial deed No. 20 dated August 13th, 1999 of Fathiah Helmi, S.H., notary in Jakarta. The company's articles of association has been amended several times, and the latest amended on August 30, 2004 concerning company's plan for public offering. The company divides business into 2 divisions, stock brokerage and investment management division.
Read more on PEGE →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
